| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 08:39:29 UTC |
|---|
| Update Date | 2022-11-30 19:26:41 UTC |
|---|
| HMDB ID | HMDB0116597 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) |
|---|
| Description | PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylglycerol - a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of eicosatetraenoic acid at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. Phosphatidylglycerol is present at a level of 1-2% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant (up to 11% of the total). It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for cardiolipin synthesis. |
|---|
| Structure | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC)OC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC InChI=1S/C46H75O10P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-45(49)53-41-44(42-55-57(51,52)54-40-43(48)39-47)56-46(50)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h5-8,11-14,17-20,23-26,43-44,47-48H,3-4,9-10,15-16,21-22,27-42H2,1-2H3,(H,51,52)/b7-5-,8-6-,13-11-,14-12-,19-17-,20-18-,25-23-,26-24-/t43-,44+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Eicosatetraenoyl-2-eicosatetraenoyl-sn-glycero-3-phospho-(1'-glycerol) | HMDB | | 1-Eicosatetraenoyl-2-eicosatetraenoyl-sn-glycero-3-phosphoglycerol | HMDB | | PG(20:4/20:4) | HMDB | | PG(20:4N3/20:4N3) | HMDB | | PG(20:4W3/20:4W3) | HMDB | | PG(40:8) | HMDB | | Phosphatidylglycerol(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) | HMDB | | Phosphatidylglycerol(20:4/20:4) | HMDB | | Phosphatidylglycerol(20:4n3/20:4n3) | HMDB | | Phosphatidylglycerol(20:4W3/20:4W3) | HMDB | | Phosphatidylglycerol(40:8) | HMDB | | 1,2-Dieicsoatetraenoyl-rac-glycero-3-phosphoglycerol | HMDB | | GPG(20:4/20:4) | HMDB | | GPG(40:8) | HMDB | | 1,2-Di(8Z,11Z,14Z,17Z-eicosapentaenoyl)-rac-glycero-3-phosphoglycerol | HMDB | | 1,2-Di(8Z,11Z,14Z,17Z-eicosapentaenoyl)-rac-glycero-3-phospho-(1'-glycerol) | HMDB | | [(2R)-2,3-Bis[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propoxy][(2S)-2,3-dihydroxypropoxy]phosphinate | HMDB | | 1-eicosatetraenoyl-2-eicosatetraenoyl-sn-glycero-3-phospho-(1'-glycerol) | SMPDB, HMDB | | 1-eicosatetraenoyl-2-eicosatetraenoyl-sn-glycero-3-phosphoglycerol | SMPDB, HMDB | | PG(20:4/20:4) | SMPDB, HMDB | | PG(20:4n3/20:4n3) | SMPDB, HMDB | | PG(20:4w3/20:4w3) | SMPDB, HMDB | | PG(40:8) | SMPDB, HMDB | | Phosphatidylglycerol(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) | SMPDB, HMDB | | Phosphatidylglycerol(20:4/20:4) | SMPDB, HMDB | | Phosphatidylglycerol(20:4n3/20:4n3) | SMPDB, HMDB | | Phosphatidylglycerol(20:4w3/20:4w3) | SMPDB, HMDB | | PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) | SMPDB |
|
|---|
| Chemical Formula | C46H75O10P |
|---|
| Average Molecular Weight | 819.07 |
|---|
| Monoisotopic Molecular Weight | 818.509785613 |
|---|
| IUPAC Name | [(2R)-2,3-bis[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propoxy][(2S)-2,3-dihydroxypropoxy]phosphinic acid |
|---|
| Traditional Name | (2R)-2,3-bis[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propoxy((2S)-2,3-dihydroxypropoxy)phosphinic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC)OC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC |
|---|
| InChI Identifier | InChI=1S/C46H75O10P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-45(49)53-41-44(42-55-57(51,52)54-40-43(48)39-47)56-46(50)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h5-8,11-14,17-20,23-26,43-44,47-48H,3-4,9-10,15-16,21-22,27-42H2,1-2H3,(H,51,52)/b7-5-,8-6-,13-11-,14-12-,19-17-,20-18-,25-23-,26-24-/t43-,44+/m0/s1 |
|---|
| InChI Key | YICHHSJHMIIOIM-QXTNZHIRSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phosphatidylglycerols. These are glycerophosphoglycerols in which two fatty acids are bonded to the 1-glycerol moiety through ester linkages. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphoglycerols |
|---|
| Direct Parent | Phosphatidylglycerols |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerophosphoglycerol
- Fatty acid ester
- Dialkyl phosphate
- Dicarboxylic acid or derivatives
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Fatty acyl
- 1,2-diol
- Carboxylic acid ester
- Secondary alcohol
- Carboxylic acid derivative
- Organic oxide
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Primary alcohol
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/18:1(11Z)/18:1(11Z)) (PathBank: SMP0080016)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/16:0) (PathBank: SMP0095291)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0100031)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/18:1(9Z)) (PathBank: SMP0072239)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086726)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086727)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/22:0) (PathBank: SMP0100032)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)) (PathBank: SMP0100033)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/22:0/22:0) (PathBank: SMP0100034)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/22:0/22:1(13Z)) (PathBank: SMP0100035)
- Cardiolipin Biosynthesis CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0100036)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 4.26 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 34.7377 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.86 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5942.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 353.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 325.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 301.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1198.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1960.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1026.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 186.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3567.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1361.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 3027.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1410.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 798.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 255.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 656.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 11.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC)OC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC | 5902.7 | Standard polar | 33892256 | | PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC)OC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC | 4893.8 | Standard non polar | 33892256 | | PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC)OC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC | 5794.4 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-19 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-19 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-19 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) 10V, Positive-QTOF | splash10-0gb9-5152182190-96ce3954cd9ec6ac9ebf | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) 20V, Positive-QTOF | splash10-0ky0-7294253430-eda579defda332a48a41 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) 40V, Positive-QTOF | splash10-0a4j-9046123300-aca719453feb5eb2ff63 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) 10V, Negative-QTOF | splash10-0udr-1279060440-bb5230fa1171d7a1bd59 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) 20V, Negative-QTOF | splash10-0ug0-9458230200-bbed2be5fabdc8d71bec | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) 40V, Negative-QTOF | splash10-004i-9001100000-454c2fa1df35246dfcb2 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) 10V, Negative-QTOF | splash10-014i-0000000090-0b4d0111725d5ac858ce | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) 20V, Negative-QTOF | splash10-0uxr-0109130090-41fd4793ba449de09942 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) 40V, Negative-QTOF | splash10-0uxr-0309130090-25e2db7fda77df2aee62 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|